TY  - GEN
AU  - Gridelli,C
AU  - Curcio,C
AU  - Iaffaioli,R V
AU  - Brancaccio,L
AU  - D'Aprile,M
AU  - Gebbia,V
AU  - Rossi,A
AU  - Tortoriello,A
AU  - Veltri,E
AU  - Maione,P
AU  - Barbarisi,A
AU  - Gallo,C
AU  - Guida,C
AU  - Perrone,F
TI  - Carboplatin + epirubicin +VP-16 + lenograstim followed by radiotherapy + carboplatin as radiosensitizer in limited small cell lung cancer. A multicenter phase II study
SN  - 0250-7005
PY  - 2002///0419
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Carboplatin
KW  - administration & dosage
KW  - Carcinoma, Small Cell
KW  - drug therapy
KW  - Combined Modality Therapy
KW  - Epirubicin
KW  - Etoposide
KW  - Female
KW  - Granulocyte Colony-Stimulating Factor
KW  - Humans
KW  - Lenograstim
KW  - Lung Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Radiation-Sensitizing Agents
KW  - Recombinant Proteins
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study
ER  -